Health care facilities could claim tax credits for eligible anesthesia costs paid or incurred in 2027–2029, with gas-purchase credits tied to yearly reduction targets.
For 2027–2029 costs, gas-credit rates would require at least a 10% cut from the previous tax year in desflurane and nitrous oxide purchases’ warming impact per average inpatient bed.
For 2027–2029 costs, only isoflurane and sevoflurane purchases would count toward the gas-purchase credit for hospitals, certain outpatient surgery centers, and other designated facilities.
Covered facilities could receive up to $1,500 per mobile anesthesia machine per tax year for repairs or changes that let it use isoflurane or sevoflurane, for costs paid or incurred in 2027–2029.
Gas-credit rates would depend on certified yearly reductions. The test would compare desflurane and nitrous oxide purchases’ 100-year warming impact per average inpatient bed with the preceding tax year. Reductions of at least 10% but less than 25% would earn a 15% credit. Reductions of at least 25% but less than 50% would earn 25%; reductions of at least 50% would earn 50%. Eligible costs would have to be paid or incurred after December 31, 2026, through December 31, 2029.
Only spending on isoflurane or sevoflurane would count as eligible gas purchases. Hospitals, certain outpatient surgery centers, and other facilities chosen by the official administering the credit would be covered. Eligible costs would have to be paid or incurred after December 31, 2026, through December 31, 2029.
Covered facilities could claim a tax credit for repairing or modifying mobile anesthesia machines to use isoflurane or sevoflurane. Hospitals, certain outpatient surgery centers, and other facilities chosen by the official administering the credit would be covered. The machine credit would cover eligible costs up to $1,500 per machine per tax year. The machine portion does not state a yearly gas-reduction requirement. Both the gas-purchase and machine credits would apply to costs paid or incurred after December 31, 2026, through December 31, 2029.
No hearings or votes scheduled.